JOYCE YEUNG: Open Payments
NPI 1417203456 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,057 in 102 payments from 13 companies in 2025. Trend: 2023 $2,461 · 2024 $2,807 · 2025 $3,057
Food & beverage: $3,057
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $698 |
| Gilead Sciences, Inc. | 14 | $514 |
| AstraZeneca Pharmaceuticals LP | 21 | $503 |
| Galderma Laboratories, L.P. | 20 | $391 |
| GlaxoSmithKline, LLC. | 7 | $360 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $170 |
| Almatica Pharma LLC | 3 | $67 |
| Novo Nordisk Inc | 3 | $41 |
| Exact Sciences Corporation | 1 | $23 |
Products named: EVENITY, NEMLUVIO, BREZTRI, FARXIGA, Kerendia, SHINGRIX, REPATHA, AREXVY.
Industry payments across NY — which companies pay providers there.
